Why GoodRx Holdings, Inc.’s (GDRX) Stock Is Down 5.43%
As of Thursday, July 30, GoodRx Holdings, Inc.’s GDRX share price has dipped by 5.43%, which has investors questioning if this is right time to buy.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
Commentary & Analysis
Why GoodRx Holdings, Inc.’s (GDRX) Stock Is Up 6.08%
As of Wednesday, July 01, GoodRx Holdings, Inc.’s GDRX share price has surged by 6.08%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why GoodRx Holdings, Inc.’s (GDRX) Stock Is Down 6.14%
As of Friday, June 05, GoodRx Holdings, Inc.’s GDRX share price has dipped by 6.14%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why GoodRx Holdings, Inc.’s (GDRX) Stock Is Up 6.05%
As of Thursday, June 04, GoodRx Holdings, Inc.’s GDRX share price has surged by 6.05%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why GoodRx Holdings, Inc.’s (GDRX) Stock Is Down 5.59%
As of Wednesday, June 03, GoodRx Holdings, Inc.’s GDRX share price has dipped by 5.59%, which has investors questioning if this is right time to buy.Michael Rose
Financial Summary
| Share Statistics | GDRX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,039.7 | $179.6 | 46% |
|
| Shares Out (Mil) | 341.4 | 47.9 | 84% |
|
| Institutional Ownership | 81.5% | 78.6% | 50% |
|
| Float (Mil) | 91.6 | 40.1 | 60% |
|
| Beta | 1.62 | 1.22 | 85% |
|
| Avg Daily Volume (000s) | 1,061 | 205 | 72% |
|
| Price Change (52-week) |
(37.2%) | 41.0% | 21% |
|
| Growth | GDRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 7.7% | 13.7% | 49% |
|
| Net Income (5yr) | 16.0% | (1.0%) | 65% |
|
| EPS (5yr) | 15.8% | 15.5% | 59 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (16.6%) | (15.5%) | 43% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 12 | 12 | 12 | |
| Current EPS | $0.080 | $0.309 | $0.357 | |
| Month Ago EPS | $0.080 | $0.309 | $0.358 | |
| # Rev Up | 0 | 0 | 1 | |
| # Rev Down | 1 | 1 | 0 | |
| Three Months Ago EPS | $0.080 | $0.317 | $0.369 | |
| Year/Year Chg | 2,567% | 263.5% | 408.2% | |
| Financials | GDRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $788 | $192 | 47% |
|
| Net Income (TTM) (Mil) | $21 | ($9) | 50% |
|
| EPS (TTM) | $0.059 | ($0.500) | 42% |
|
| Operating Cash Flow (TTM) (Mil) | $170 | $8 | 58% |
|
| Net Cash Flow (TTM) (Mil) | ($65) | ($3) | 17% |
|
| Long-Term Debt (Q1) (Mil) | $531 | $14 | 60% |
|
| Enterprise Value (Q1) (Mil) | $1,173 | $215 | 43% |
|
| Valuation | GDRX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.67 | 1.22 | 44% |
|
| P/E | 52.0 | 36.1 | 84% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 3.3 | 2.0 | 80% |
|
| Ratios | GDRX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 91.8% | 61.6% | 94% |
|
| Net Margin | 2.6% | (29.3%) | 40% |
|
| ROA | 1.2% | (21.9%) | 49% |
|
| ROE | 3.2% | (1.4%) | 40% |
|
| Liabilities to Assets | 69.2% | 33.3% | 64% |
|
| F-Score | 4 | 4 | 34% |
|
GoodRx Holdings, Inc. did not pass any screens on 7/31/2026.
